VEVEY, Switzerland—For most of the past decade, Nestle bought its way into vitamins. On Wednesday it agreed to sell the mainstream part of that business for $1 billion, the clearest sign yet of how the Swiss food giant’s new chief executive intends to reshape the 160-year-old company.
The buyer is Yellow Wood Partners, a U.S. private-equity firm that specializes in consumer brands. The deal covers Nestle’s mainstream vitamins, minerals and dietary-supplements operations, including seven brands and a U.S. private-label supplements business. Nestle said it expects the transaction to close in the first half of 2027.
Nestle described the sale as a key step in a portfolio strategy led by Philipp Navratil, its new chief executive, and framed it in the language of focus. The company will concentrate its resources and management attention on coffee, pet care, nutrition, and food and snacks, the categories it calls its core growth engines.
The sale unwinds part of a bet the company placed under previous management. During the late 2010s Nestle moved aggressively into health science, buying U.S. supplement makers and assembling a shelf of brands that promised faster growth and richer margins than packaged food. The mainstream vitamin aisle turned out to be less forgiving than the pitch. Growth slowed as online retailers and store brands pressed prices, and the segment drifted toward the promotional discounting that packaged-food companies know all too well.
What Nestle is giving up, in other words, is the commodity end of the health aisle: brands that compete on price, plus the private-label business, store-brand supplements made for U.S. retailers, where the real customer is the grocer rather than the person at the pharmacy counter.
Yellow Wood, for its part, has built a practice of buying brands that large consumer companies decide they no longer want to run, then operating them with a leaner cost structure and a sharper focus on the products that actually make money. Its model assumes that a brand’s problems are often the parent company’s overhead rather than the brand itself.
For Nestle, the transaction is about more than vitamins. The company has spent years trying to convince investors that it can grow again, and a portfolio that stretches across dozens of categories has made the case harder to make. Mr. Navratil’s response, of which the vitamin sale is the most visible piece so far, is to define the company more narrowly and put capital behind the categories where it already leads.
The categories he is protecting are telling. Coffee is Nestle’s largest and most profitable business, anchored by names that appear in kitchens around the world. Pet care has been its fastest-growing large division. Nutrition, meaning infant formula and clinical nutrition rather than store shelves, carries margins that mainstream supplements never delivered. Snacks round out the list. The distinction between what was sold and what remains is deliberate: supplements sold in drugstore aisles are a different business from the formula Nestle sells to parents and the nutrition it sells to hospitals.
The price tag is modest next to Nestle’s overall scale; the company sells well over one hundred billion dollars of food a year. The significance of the deal lies in what it says about direction, not size. A company that once defined growth as adding categories is now defining it as winning in fewer of them.
For the seven brands and the private-label unit, ownership by Yellow Wood will mean a different kind of parent: shorter reporting lines, harder cost targets, and constant attention to which products earn their place on the shelf. Buyout-owned consumer brands typically run leaner, and retailers should expect the assortment to change as the new owner concentrates volume on its best sellers.
The long runway to closing, in the first half of 2027, reflects the mechanics of separation. Brand registrations, supply contracts, retailer agreements and employees all have to move from Nestle’s systems to Yellow Wood’s, and both sides will use the time to complete financing and the customary clearances a deal of this size requires.
The sale is unlikely to be the last disposal. Analysts who follow the company expect Mr. Navratil to keep pruning, and executives have signaled that capital and attention will follow the core categories. For Mr. Navratil, the deal puts a price on his strategy, $1 billion, and a date on it. For investors who have listened to years of turnaround talk, it is evidence that the talk is turning into transactions. Whether the sharper Nestle grows faster is a question the next several quarters will answer, but the direction of travel is no longer in doubt: coffee, pets, nutrition and snacks, and very little else.
